WOODLAND HILLS, Calif., Dec. 10, 2012 /PRNewswire/ -- GrowLife, Inc. (OTCQB: PHOT), a completely legal provider of highly effective indoor growing technologies to the blossoming marijuana industry, today announced that its Chairman and CEO Sterling Scott appeared on MoneyTV with Donald Baillargeon on December 7, 2012 – a financial program that's syndicated to more than 150 million homes around the world. The interview can be viewed on various television networks or at http://www.moneytv.net. "We concentrate on products that improve the user experience with respect to growing," said CEO Sterling Scott in the interview with MoneyTV. "It's an exciting time for us [as] ... one of a very small number of fully-reporting public companies ... supporting the medical marijuana industry in the United States ... distributing products that are used by large and small growers." The company will be conducting another interview on Thursday, December 13, 2012, as well as additional follow up interviews over the next two months. The interviews can be viewed on various television networks or online at http://www.moneytv.net. "We are excited to spread the word about our company to hundreds of millions of new potential investors around the world," said Mr. Scott. "With the passage of recent recreational and medicinal marijuana regulations in the U.S., we view this as an optimal time to reach out to various media outlets. MoneyTV is just one part of a growing effort in-house to build awareness of our company within the investment community as we concentrate on generating long-term shareholder value by focusing on revenue growth and reaching profitability." GrowLife's consortium of companies actively participate in all channels of commerce for distribution and sales, including operating on-line and retail outlets for direct consumer sales and the supply of specialty GrowLife company products to wholesale and retail channels. And, while supporting progressive normalization of cannabis laws, the company does not grow, sell or distribute any substances that violate U.S. law or the Federal Controlled Substances Act.